Skip to main content
Veterinary Medicines

CANVAC R

Authorised
  • Rabies virus, strain PV Op VB X/96, Inactivated

Product identification

Medicine name:
CANVAC R
Active substance:
  • Rabies virus, strain PV Op VB X/96, Inactivated
Target species:
  • Fur animals
  • Cattle
  • Equid
  • Dog
  • Goat
  • Sheep
  • Cat
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Rabies virus, strain PV Op VB X/96, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Fur animals
    • Cattle
      • Meat and offal
        0
        day
    • Equid
      • Meat
        0
        day
    • Dog
    • Goat
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Cat
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120305
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 17/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."